Abbott | ABT - Ebitda


Abbott reported $3.27B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Agilent USD 456M 84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio-Rad Laboratories USD 983.8M 1.36B Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Danaher USD 1.92B 204M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Pfizer USD 5.99B 5.23B Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
Solventum Corp USD 437M 0 Mar/2026
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025